Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shanxi Guangsheng Medicinal Capsule is a Chinese pharmaceutical excipient and empty hard capsule manufacturer serving pharmaceutical and nutraceutical companies globally. The company produces a broad portfolio of gelatin, HPMC, pullulan, enteric, fish skin gelatin, and other specialty capsules, along with customized capsule solutions and related technical support. Founded operationally in 1983 and legally incorporated in 1997, it has scaled into one of China's largest capsule manufacturers, with large automated production capacity and exports to more than 30 countries. The business is manufacturing- and supply-focused rather than a therapeutic drug developer, so it does not have a traditional biotech pipeline. Advent acquired a majority stake in 2021, and the company continues to operate under the GS Capsule brand.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shanxi Guangsheng Medicinal Capsule.